Mike Karim

CEO, Oxford Endovascular Ltd

Premium Member

Oxford, UK


Mike is the CEO and co-founder of Oxford Endovascular Ltd, a spinout from Oxford University.

The company is developing a revolutionary medical device, a next generation flow diverter, to treat brain aneurysms; a life-threatening disease affecting 1 in 50 persons in a strongly growing market valued over $1 billion. In 2017 it won ‘Best Med-Tech Start-Up’ at the Oxford Bio Network awards, 1st place at the BioTrinity ‘Perfect Pitch’ competition and an award at the ‘European Health Catapult’ finals. It has won significant non-dilutive grants from the European Commission’s prestigious Horizon 2020 program as well as Innovate UK. Mike has raised over $20m from investors to support the company’s development activities.

Mike has 30 years growing international businesses in large corporations & start-ups and is experienced in strategic planning, execution, team building, gaining regulatory approvals & fund raising.

Mike mentors budding entrepreneurs, is a panellist at industry conferences, sits on the ‘Medfit’ organisation steering committee and a sub board of ABHI.

He studied Pre-Clinical Medicine, Physiology & Pharmacology at Southampton University and holds an MBA from Henley Business School, UK.

To discover and to connect with all our global community of members, apply now for a membership